In an AAA-recipient subgroup, ARID1A and EYS retained independent prognostic significance for adverse OS (ARID1A, HR 9.835, p = 0.041; EYS, HR 2.433; p = 0.009) and DSS (ARID1A, HR 9.835, p = 0.041; EYS, HR 2.433; p = 0.009) (Table S2). Here, ARID1A is linked to triple-A syndrome.